Triptorelin acetate 3.75 mg, a 28‐day, prolonged‐release GnRH agonist approved for endometriosis treatment,13 has been shown to decrease endometriosis symptom severity and improve reproductive function.3, 14, 15, 16, 17. This evidence concerns the gene GNRH1 and endometriosis.